Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Actiza 1% clindamycin foam: CNCT started in the first of two planned 12-week Phase III trials of Actiza to treat acne. The Phase III program for Actiza is expec

Connetics Corp. (CNCT), Palo Alto, Calif.
Product: Actiza

Read the full 83 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE